tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PRME Stock Latest News

Oppenheimer bullish on Prime Medicine, initiates with an Outperform
The FlyOppenheimer bullish on Prime Medicine, initiates with an Outperform
12d ago
PRME
Prime Medicine initiated with an Outperform at Oppenheimer
PremiumThe Fly
Prime Medicine initiated with an Outperform at Oppenheimer
12d ago
PRME
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
20d ago
ET
IRE
Prime Medicine Reports 2025 Results, Advances Gene Editing Pipeline
PremiumCompany Announcements
Prime Medicine Reports 2025 Results, Advances Gene Editing Pipeline
21d ago
8K
PRME
Prime Medicine reports FY25 EPS ($1.35) vs ($1.65) last year
PremiumThe Fly
Prime Medicine reports FY25 EPS ($1.35) vs ($1.65) last year
21d ago
PRME
PRME Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsPRME Earnings Report this Week: Is It a Buy, Ahead of Earnings?
27d ago
PRME
Prime Medicine Advances Wilson Disease Pipeline With New Prescreening Study
Premium
Company Announcements
Prime Medicine Advances Wilson Disease Pipeline With New Prescreening Study
2M ago
PRME
Prime Medicine updates corporate strategy for Prime Editing platform
Premium
Company Announcements
Prime Medicine updates corporate strategy for Prime Editing platform
2M ago
8K
PRME
Ametek, MindMed, Atai, Prime and KB Home Trending
PremiumWeekend Updates
Ametek, MindMed, Atai, Prime and KB Home Trending
3M ago
AME
KBH
Prime Medicine initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Prime Medicine initiated with an Outperform at LifeSci Capital
3M ago
PRME
Prime Medicine: Buy Rating on Prime Editing Platform Targeting High-Value Liver and Lung Genetic Diseases, Led by PM577 in Wilson’s Disease
PremiumRatings
Prime Medicine: Buy Rating on Prime Editing Platform Targeting High-Value Liver and Lung Genetic Diseases, Led by PM577 in Wilson’s Disease
3M ago
PRME
Prime Medicine announces NEJM publication of PM359 data
PremiumThe Fly
Prime Medicine announces NEJM publication of PM359 data
4M ago
PRME
Citizens JMP healthcare analysts hold an analyst/industry conference
PremiumThe FlyCitizens JMP healthcare analysts hold an analyst/industry conference
4M ago
BNTC
CRSP
Prime Medicine transferred with Neutral rating at JPMorgan
Premium
The Fly
Prime Medicine transferred with Neutral rating at JPMorgan
4M ago
PRME
Cautious Hold Rating for Prime Medicine, Inc. Amid Promising Preclinical Results and Extended Development Timeline
Premium
Ratings
Cautious Hold Rating for Prime Medicine, Inc. Amid Promising Preclinical Results and Extended Development Timeline
4M ago
PRME
Prime Medicine’s Promising Advances in Gene Editing Justify Buy Rating
PremiumRatings
Prime Medicine’s Promising Advances in Gene Editing Justify Buy Rating
4M ago
PRME
Prime Medicine price target lowered to $4.25 from $5 at Citi
PremiumThe Fly
Prime Medicine price target lowered to $4.25 from $5 at Citi
4M ago
PRME
Prime Medicine Advances Genetic Therapy Pipeline in Q3 2025
PremiumCompany Announcements
Prime Medicine Advances Genetic Therapy Pipeline in Q3 2025
5M ago
PRME
Prime Medicine files automatic mixed securities shelf
PremiumThe Fly
Prime Medicine files automatic mixed securities shelf
5M ago
PRME
Prime Medicine reports Q3 EPS (32c), consensus (25c)
PremiumThe FlyPrime Medicine reports Q3 EPS (32c), consensus (25c)
5M ago
PRME
Prime Medicine appoints Hawryluk as Chief Business Officer
Premium
The Fly
Prime Medicine appoints Hawryluk as Chief Business Officer
5M ago
PRME
Intellia Therapeutics price target lowered to $9 from $14 at Wedbush
Premium
The Fly
Intellia Therapeutics price target lowered to $9 from $14 at Wedbush
5M ago
BEAM
NTLA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >